El colesterol y los fitoesteroles son esteroles, compuestos grasos esenciales para muchos procesos biológicos, como el funcionamiento de las membranas celulares. Hasta ahora, se creía que los fitoesteroles eran exclusivos de las plantas, como el colesterol es típico de los anima …
Animal cuyo cuerpo sin boca ni tripa fabrica sustancias vegetales Read More »
Aiosyn, a medical software company that develops AI-powered pathology solutions, has been awarded a EUR 1.300.000 EFRO-OOST grant alongside Radboud university medical center and Pathologie-DNA to accelerate the development of AI technology for breast and skin cancer diagnostics.
IDEAYA Biosciences, Inc., a precision medicine oncology company committed to the discovery and development of targeted therapeutics, provided a business update and announced financial results for the first quarter ended March 31, 2023.
BrainStorm Cell Therapeutics Inc. announced that it will hold a conference call to update shareholders on financial results for the First Quarter ended March 31, 2023, and provide a corporate update, at 8:00 a.m. Eastern Time on Monday, May 15th.
On April 22, Neuboron Medical Group, a leading global Accelerator-based Boron Neutron Capture Therapy total solution provider, and Xiamen Humanity Hospital collaborated to co-host the Xiamen BNCT Technology Forum 2023 at the BNCT center in XHH.
El Efecto Mandela consiste en una situación en la que hay diversas personas que creen que ocurrió un evento, pero no fue de esa manera, siendo un fenómeno que puede observarse en acontecimientos históricos, películas, series de televisión, entre ot …
Diagnostic company SphingoTec has been successfully re-certified according to ISO 13485 and received its first IVDR certificate for its IVD product sphingotest® penKid®.
Theranexus and the Beyond Batten Disease Foundation, have announced receipt of approval from the Food and Drug Administration for the design and primary and secondary endpoints of the pivotal Phase III trial for Batten disease CLN3, at a meeting with the Division of Rare Diseases and Medical Genetics held in mid-April.
Spago Nanomedical Towards clinic with Tumorad®
Spago Nanomedical Interim Report January-March 2023 Read More »
Biophytis SA announced that it has filed for a pre-submission meeting request with the European Medicine Agency to discuss filing for conditional Marketing Authorisation in Europe for Sarconeos in the treatment of severe form of COVID-19.
